In the News

501 News Items found
Mother holding her newborn baby.
Learn how MSK experts help navigate the special needs of people who have cancer during pregnancy
Mobile Health Unit
MSK’s Mobile Health Unit provides health education, screening, and navigation services to underserved communities in the New York metro area.
DNA winding around histones
In the Lab
The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.
ContactTracing graphic
A collaboration between MSK and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023
New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease, indicating that cancer diagnostics need to go beyond the analysis of DNA mutations.
MSK nurse Margaret Bediones
Learn how Memorial Sloan Kettering Cancer Center nurse Margaret Bediones improves the health of underserved communities at the MSK Ralph Lauren Center in Harlem through community outreach focused on cancer prevention and screening.
Pictured: Jan Grimm
In the Lab
Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.
Immune cells surrounding a cancer cell
In the Lab
Scientists have learned that cutting a T cell’s brakes can have unexpected consequences.
a lab coat hangs in an MSK lab
MSK Research Highlights, November 6, 2024
New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.